Strides Pharma Science Ltd - Stock Price

As on21 Sep 2021 10:54 AM
  • NSE : STAR
  • BSE : 532531
  • ISIN CODE : INE939A01011
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Strides Pharma Science Ltd is not traded on BSE/NSE
-1.18 %-6.9
-1.5 %-8.8

Balance Sheet

Parameter MAR 21  MAR 20  YoY %Change
Share Capital896.81895.650.13
    Equity - Authorised1883.701767.506.57
    Equity - Issued896.81895.650.13
    Equity Paid Up896.81895.650.13
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value10.0010.000.00
Share Warrants & Outstandings47.2057.24-17.54
Total Reserves26822.6024321.2810.28
    Securities Premium17272.6717008.371.55
    Capital Reserves214.84425.46-49.50
    Profit & Loss Account Balance4849.502344.23106.87
    General Reserves4015.694010.280.13
    Other Reserves469.90532.94-11.83
Reserve excluding Revaluation Reserve26822.6024321.2810.28
Revaluation reserve0.000.000.00
Shareholder's Funds27766.6125274.179.86
Minority Interest373.41672.38-44.46
Long-Term Borrowings0.000.000.00
Secured Loans8734.296017.9145.14
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks9776.137308.2233.77
    Term Loans - Institutions0.000.000.00
    Other Secured-1041.84-1290.3119.26
Unsecured Loans91.4921.18331.96
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.
    Loans - Others91.8021.42328.57
    Other Unsecured Loan-0.31-0.24-29.17
Deferred Tax Assets / Liabilities-1518.73-1777.5914.56
    Deferred Tax Assets2620.132781.70-5.81
    Deferred Tax Liability1101.401004.119.69
Other Long Term Liabilities2872.453235.44-11.22
Long Term Trade Payables0.000.000.00
Long Term Provisions2464.99639.52285.44
Total Non-Current Liabilities12644.498136.4655.41
Current LiabilitiesNANANA
Trade Payables11786.247977.4847.74
    Sundry Creditors11786.247977.4847.74
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities3765.773544.906.23
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers239.01313.96-23.87
    Interest Accrued But Not Due47.85103.67-53.84
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities3478.913127.2711.24
Short Term Borrowings10238.3812287.75-16.68
    Secured ST Loans repayable on Demands9622.6712244.35-21.41
    Working Capital Loans- Sec6810.237139.02-4.61
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans-6194.52-7095.6212.70
Short Term Provisions1593.091638.44-2.77
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax351.18383.20-8.36
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions1241.911255.24-1.06
Total Current Liabilities27383.4825448.577.60
Total Liabilities68167.9959531.5814.51
Gross Block28412.7825343.7912.11
Less: Accumulated Depreciation6901.495085.3035.71
Less: Impairment of Assets0.000.000.00
Net Block21511.2920258.496.18
Lease Adjustment A/c0.000.000.00
Capital Work in Progress2276.021480.5553.73
Non Current Investments6662.315032.3732.39
Long Term Investment6662.315032.3732.39
Long Term Loans & Advances1858.002108.21-11.87
Other Non Current Assets5490.364281.9428.22
Total Non-Current Assets39995.6535810.4711.69
Current Assets Loans & AdvancesNANANA
Currents Investments994.121189.68-16.44
    Raw Materials5516.965067.218.88
    Work-in Progress385.62609.48-36.73
    Finished Goods5359.471826.73193.39
    Packing Materials0.000.000.00
    Stores  and Spare223.68175.3127.59
    Other Inventory521.30146.66255.45
Sundry Debtors11068.599316.9418.80
    Debtors more than Six months0.000.000.00
    Debtors Others11688.7710001.1716.87
Cash and Bank1797.652370.97-24.18
    Cash in hand2.962.4321.81
    Balances at Bank1601.282280.13-29.77
    Other cash and bank balances193.4188.41118.76
Other Current Assets982.22835.6917.53
    Interest accrued on Investments39.8038.453.51
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans14.1713.078.42
    Prepaid Expenses526.86484.208.81
    Other current_assets401.39299.9733.81
Short Term Loans and Advances1322.732182.44-39.39
    Advances recoverable in cash or in kind377.241056.74-64.30
    Advance income tax and TDS0.000.000.00
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances945.491125.70-16.01
Total Current Assets28172.3423721.1118.76
Net Current Assets (Including Current Investments)788.86-1727.46145.67
Miscellaneous Expenses not written off0.000.000.00
Total Assets68167.9959531.5814.51
Contingent Liabilities8416.7923788.66-64.62
Total Debt21033.8819617.397.22
Book Value309.09281.559.78
Adjusted Book Value309.09281.559.78

About Strides Pharma Science Ltd.

Strides Pharma Science Ltd. was incorporated in the year 1990. Its today's share price is 576.85. Its current market capitalisation stands at Rs 5205.29 Cr. In the latest quarter, company has reported Gross Sales of Rs. 18575.66 Cr and Total Income of Rs.19746.51 Cr. The company's management includes Manjula Ramamurthy, Homi Rustam Khusrokhan, Bharat D Shah, S Sridhar, Deepak Vaidya, Kausalya Santhanam, Badree Komandur, R Ananthanarayanan, Arun Kumar.

It is listed on the BSE with a BSE Code of 532531 , NSE with an NSE Symbol of STAR and ISIN of INE939A01011. It's Registered office is at 201, Devavrata,Sector-17,VashiNavi Mumbai-400705, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, Deloitte Haskins & Sells, Deloittee Haskins & Sells, Shivadas Kallianpur & Associates, SR Batliboi & Associates

Latest News